博拓生物
(688767)
| 流通市值：54.33亿 | | | 总市值：54.33亿 |
| 流通股本：1.49亿 | | | 总股本：1.49亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 312,178,379.69 | 214,684,129.57 | 89,376,734.08 | 448,012,337.89 |
| 营业总成本 | 331,930,411.12 | 236,469,943.71 | 103,998,265.43 | 415,659,935.1 |
| 其他经营收益 | | | | |
| 营业利润 | -23,031,093.01 | -24,089,731.28 | -14,642,878.23 | 50,524,884.9 |
| 利润总额 | -23,400,803.95 | -23,622,640.42 | -14,423,839.83 | 49,681,667.11 |
| 净利润 | -17,804,262.73 | -17,094,519.68 | -10,532,237.7 | 47,126,834.92 |
| 每股收益 | | | | |
| 其他综合收益 | 1,324,449.71 | 754,523.45 | 302,036.41 | 297,744.75 |
| 综合收益总额 | -16,479,813.02 | -16,339,996.23 | -10,230,201.29 | 47,424,579.67 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,391,420,517.37 | 1,446,061,760.02 | 1,580,331,727.86 | 1,661,485,204.52 |
| 非流动资产: | | | | |
| 非流动资产合计 | 990,200,003.24 | 959,415,475.72 | 905,665,233.93 | 877,938,816.49 |
| 资产总计 | 2,381,620,520.61 | 2,405,477,235.74 | 2,485,996,961.79 | 2,539,424,021.01 |
| 流动负债: | | | | |
| 流动负债合计 | 131,547,993.58 | 152,109,713.91 | 111,982,115.01 | 157,976,497.22 |
| 非流动负债: | | | | |
| 非流动负债合计 | 108,409,580.06 | 108,831,776.18 | 9,751,160.28 | 10,191,636.08 |
| 负债合计 | 239,957,573.64 | 260,941,490.09 | 121,733,275.29 | 168,168,133.3 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,141,421,951.73 | 2,140,968,969.16 | 2,360,480,529.97 | 2,369,789,814.77 |
| 股东权益合计 | 2,141,662,946.97 | 2,144,535,745.65 | 2,364,263,686.5 | 2,371,255,887.71 |
| 负债和股东权益合计 | 2,381,620,520.61 | 2,405,477,235.74 | 2,485,996,961.79 | 2,539,424,021.01 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 394,239,867.05 | 236,997,246.83 | 107,079,239.33 | 574,024,272.61 |
| 经营活动现金流出小计 | 335,776,952.09 | 228,882,875.68 | 125,067,771.78 | 467,556,172.17 |
| 经营活动产生的现金流量净额 | 58,462,914.96 | 8,114,371.15 | -17,988,532.45 | 106,468,100.44 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,910,874,169.53 | 2,000,551,687.37 | 909,703,750.15 | 5,481,408,505.61 |
| 投资活动现金流出小计 | 2,763,721,538.3 | 1,783,909,023.8 | 958,847,784 | 5,349,705,038.09 |
| 投资活动产生的现金流量净额 | 147,152,631.23 | 216,642,663.57 | -49,144,033.85 | 131,703,467.52 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 102,640,000 | 102,640,000 | 2,640,000 | 3,147,500 |
| 筹资活动现金流出小计 | 225,251,162.59 | 215,793,333.8 | - | 161,204,403.14 |
| 筹资活动产生的现金流量净额 | -122,611,162.59 | -113,153,333.8 | 2,640,000 | -158,056,903.14 |
| 汇率变动对现金及现金等价物的影响 | -43,447,235.84 | -32,503,908.83 | -17,537,266.19 | -12,677,811.46 |
| 现金及现金等价物净增加额 | 39,557,147.76 | 79,099,792.09 | -82,029,832.49 | 67,436,853.36 |
| 期末现金及现金等价物余额 | 1,210,753,432.28 | 1,250,296,076.61 | 1,089,166,452.03 | 1,171,196,284.52 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 79,099,792.09 | - | 67,436,853.36 |